Three months ago, Knowles delivered its most confident quarter in at least a year. It finally put a hard number on fiscal 2026, guiding for 10% to 12% revenue growth after spending several quarters edging up from a 4% to 6% investor-day target. It reported record Precision Devices bookings and talked up a defense cycle that could gather pace into 2027 and 2028. The market shrugged. The stock has slipped 6.1% since that report while the S&P 500 gained 5.4%. That gap is the setup heading into the October 22 release after the close. The question is whether the business keeps proving the bullish story or whether investors were right to stay skeptical.

The Street is asking for non-GAAP earnings of $0.36 a share on revenue of $172.3 million. That revenue figure implies growth of about 12.7% from the year-ago $152.9 million, a strong pace for a components maker, and a meaningful step up from last quarter's $166.8 million. Both numbers sit squarely at the midpoint of management's guidance of $0.34 to $0.38 and $167 million to $177 million. In other words, analysts have taken the company at its word without padding the forecast. The Earnings Whisper of $0.37 is only a penny higher, which hints at modest hopes for upside rather than a demanding hidden bar. Still, the jump from $0.27 last quarter means operating leverage has to show up on schedule.

Precision Devices is the engine, so it deserves most of the scrutiny. The segment grew 25% to $98 million last quarter, and orders of roughly $140 million produced a book-to-bill of 1.4, the seventh straight quarter above 1. Bookings at that level should support another quarter of solid shipment growth. A book-to-bill that slips back toward 1 would not be alarming coming off a record, but it would temper the acceleration story. Margins matter just as much. Management said Precision Devices gross margin, at 40.1%, should move into the low 40s in the second half on firmer pricing, richer mix and better factory utilization. Evidence of that move would support the raised target of an EBITDA margin above 25% for the year. Two cost risks could get in the way. One is palladium, which was hedged only through the first half. The other is rising capital spending to relieve capacity constraints. Investors should also look for confirmation that the energy order, fully ramped entering the quarter with better-than-planned yields, is contributing as promised.

The soft spot is the hearing health and audio business, known as MSA. Its growth slowed to 2% last quarter after customers pulled inventory into the first half. Management has already warned of a sequential dip in the fourth quarter, though it still expects 2% to 4% for the full year. This report should show whether the slowdown is a contained timing issue or something broader. Any sign that the fourth-quarter outlook is worse than flagged would undercut confidence in the full-year guide.

Sentiment has warmed considerably. Bullish readings have roughly doubled from 21.4% before the last report to 45.3% now, even as the share price lagged. The stock, at $36.58, sits comfortably above its 200-day moving average of $32.21 and roughly in the middle of its post-earnings range of $32.16 to $40.82. That range is narrower than the previous quarter's swing, which suggests the market is waiting for proof rather than pricing in a breakout.

Ultimately, this quarter hinges on whether Knowles can reaffirm or nudge up its 10% to 12% growth outlook while showing Precision Devices margins climbing toward the low 40s. Do that, and the recent underperformance looks like an opportunity the business is closing. Fall short on margins or widen the hearing-health warning, and the skeptics will have reason to keep the stock range-bound despite the defense tailwind.